Andrew Gengos
Chief Financial Officer · Immuneering Corp
Individual
- 2025
- Jul 17, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew Gengos files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Thomas J. Schall - $101K in IMRX purchases and sales in the last 12 months
- Peter Feinberg - $87K in IMRX purchases and sales in the last 12 months
- Brett Matthew Hall - $36K in IMRX purchases and sales in the last 12 months
- Harold Eugene Brakewood - $25K in IMRX purchases and sales in the last 12 months
- Benjamin J. Zeskind - $11K in IMRX purchases and sales in the last 12 months
- Leah R. Neufeld - $11K in IMRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew Gengos?
Andrew Gengos is a corporate insider, tracked as Chief Financial Officer of Immuneering Corp (IMRX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Andrew Gengos submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
